Progesterone level on embryo transfer day and pregnancy after frozen embryo transfer
Official title: Impact of Serum Progesterone Levels on Embryo Transfer Day on Clinical Pregnancy in Frozen-thawed Embryo Transfer Cycles Using Hormone Replacement Therapy: a Prospective Observational Study
Run by Chinese University of Hong Kong · NCT07388797 · Data updated 2026-11-12
We will test whether blood progesterone levels on the day of embryo transfer affect the chance of clinical pregnancy for people having hormone-replacement frozen-thawed embryo transfers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 42 Years |
| Sex | Women only |
| Enrollment | 370 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | January 20, 2026 |
| Main results expected | June 30, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | May 11, 2026 |
| Trial ID | NCT07388797 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Infertility patients aged over 18 and under 42 with BMI under 30 who are undergoing hormone-replacement frozen embryo transfer and transferring at least one good-quality embryo are ideal candidates.
✕Probably not a fit
Patients with severe untreated endocrine disorders or significant untreated uterine pathology, those outside the age/BMI limits, or those not using HRT-FET are unlikely to benefit from these findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will record serum progesterone levels on the day of embryo transfer in HRT-FET cycles and categorize patients by those levels. Clinical pregnancy rate is the primary outcome, with biochemical pregnancy, implantation rate, early pregnancy loss, and ectopic pregnancy as secondary outcomes. Eligible participants are infertility patients aged 18–41 with BMI under 30 who transfer at least one good-quality embryo; patients with severe untreated endocrine or uterine conditions are excluded. All procedures and sample collection occur at The Chinese University of Hong Kong and outcomes will be compared across progesterone level groups.
Why it matters
Potential benefit: If a clear relationship is found, progesterone measurement on transfer day could be used to better time or tailor luteal support and improve pregnancy chances in HRT-FET cycles.
How similar studies have gone: Previous observational studies on progesterone levels at transfer have reported mixed results, so this study builds on existing but not definitive evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing FET cycles * Infertility patients aged \>18 years old and \< 42 years old * BMI \< 30 kg/m2 * Transfer of at least one good-quality embryo. Exclusion Criteria: * Severe endocrine disorders (e.g., thyroid dysfunction, premature ovarian failure). * Severe uterine factors without treatment (severe endometriosis, extensive or subendometrial fibroid, uterine adherent, endometrial polyps)
Where it's running
-
The Chinese University of Hong Kong
Hong Kong, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI tool to analyze sperm and predict their ability to help IVF/ICSI succeed
This project will test an AI platform that analyzes semen samples from men providing sperm for IVF/ICSI to see if it can predict which samples have the best chance of supporting successful IVF/ICSI outcomes.
-
What factors affect pregnancy success after IUI
This project will try to see if hormone levels on trigger day, follicle and uterine measurements, and sperm quality are linked to the chance of a clinical pregnancy after IUI for couples who had IUI cycles.
-
How male-level testosterone affects reproductive hormone cycles in people assigned female at birth
This study will test whether male-level testosterone given to transgender men starting hormone therapy changes the ovarian and pituitary hormones that control menstrual cycles compared with cisgender women.
-
Evaluating a new method for sperm capacitation
This study is testing a new method called HyperSperm to see if it can improve sperm quality for men who are having trouble with fertility.
-
Comparing Day 5 and Day 6 Embryo Transfers for Pregnancy Rates
This study is testing whether transferring embryos on day 5 or day 6 after treatment can lead to higher pregnancy rates for people undergoing fertility treatment.
-
Exploring male factors affecting fertility and pregnancy likelihood
This study is trying to find out how different male factors affect the chances of getting pregnant for couples, to help create a tool that predicts pregnancy rates and improve reproductive health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.